These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 8591581

  • 1. A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients.
    Furutani H.
    Medinfo; 1995; 8 Pt 2():909. PubMed ID: 8591581
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A, Chavali S, Kabra M, Chowdhury MR, Bharadwaj D.
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structure and function of factor IX: defects in haemophilia B.
    McGraw RA, Davis LM, Lundblad RL, Stafford DW, Roberts HR.
    Clin Haematol; 1985 Jun; 14(2):359-83. PubMed ID: 3899439
    [Abstract] [Full Text] [Related]

  • 6. Point mutations in four hemophilia B patients from China.
    Wang NS, Chen SH, Thompson AR.
    Thromb Haemost; 1990 Oct 22; 64(2):302-6. PubMed ID: 2270538
    [Abstract] [Full Text] [Related]

  • 7. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.
    Bottema CD, Ketterling RP, Ii S, Yoon HS, Phillips JA, Sommer SS.
    Am J Hum Genet; 1991 Oct 22; 49(4):820-38. PubMed ID: 1680287
    [Abstract] [Full Text] [Related]

  • 8. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I, Shinozawa K, Otaki M, Fujita S, Suzuki T, Amano K, Inaba H, Fukutake K.
    Rinsho Byori; 2009 May 22; 57(5):417-24. PubMed ID: 19522246
    [Abstract] [Full Text] [Related]

  • 9. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
    Tanimoto M, Matsushita T, Takamatsu J, Saito H.
    Rinsho Byori; 1990 Sep 22; 38(9):1041-6. PubMed ID: 2232265
    [Abstract] [Full Text] [Related]

  • 10. [The current feature of the study on human coagulation factor IX mutant].
    Yan JB.
    Yi Chuan; 2005 Sep 22; 27(5):833-8. PubMed ID: 16257919
    [Abstract] [Full Text] [Related]

  • 11. [Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].
    Mazin AL.
    Mol Biol (Mosk); 1995 Sep 22; 29(1):71-90. PubMed ID: 7723765
    [Abstract] [Full Text] [Related]

  • 12. Molecular genotyping of the Italian cohort of patients with hemophilia B.
    Belvini D, Salviato R, Radossi P, Pierobon F, Mori P, Castaldo G, Tagariello G, AICE HB Study Group.
    Haematologica; 2005 May 22; 90(5):635-42. PubMed ID: 15921378
    [Abstract] [Full Text] [Related]

  • 13. Genetic basis and carrier detection of hemophilia B of Chinese origin.
    Lin SW, Shen MC.
    Thromb Haemost; 1993 Mar 01; 69(3):247-52. PubMed ID: 8470048
    [Abstract] [Full Text] [Related]

  • 14. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe hemophilia B.
    Wang NS, Zhang M, Thompson AR, Chen SH.
    Thromb Haemost; 1990 Feb 19; 63(1):24-6. PubMed ID: 2339358
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D, Tartary M, Costa JM, Bahnak BR, Gispert-Sanchez S, Fressinaud E, Gazengel C, Meyer D, Goossens M, Lavergne JM.
    Hum Genet; 1993 Apr 19; 91(3):241-4. PubMed ID: 8478007
    [Abstract] [Full Text] [Related]

  • 17. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
    Attali O, Vinciguerra C, Trzeciak MC, Durin A, Pernod G, Gay V, Ménart C, Sobas F, Dechavanne M, Négrier C.
    Thromb Haemost; 1999 Nov 19; 82(5):1437-42. PubMed ID: 10595634
    [Abstract] [Full Text] [Related]

  • 18. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M, Matsushita T, Tanimoto M, Takahashi I, Yamamoto K, Sugiura I, Takamatsu J, Ogata K, Kamiya T, Saito H.
    Thromb Haemost; 1991 May 06; 65(5):514-20. PubMed ID: 1871712
    [Abstract] [Full Text] [Related]

  • 19. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC, Hamaguchi N, Yu YS, Shen MC, Lin SW.
    Thromb Haemost; 2000 Oct 06; 84(4):626-34. PubMed ID: 11057861
    [Abstract] [Full Text] [Related]

  • 20. Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B--Factor IXDelhi.
    Mahajan A, Sharma A, Chavali S, Kabra M, Chowdhury MR, Srinivasan N, Bharadwaj D.
    Haemophilia; 2004 Sep 06; 10(5):550-2. PubMed ID: 15357782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.